David Jollow to Liver
This is a "connection" page, showing publications David Jollow has written about Liver.
Connection Strength
0.746
-
Macrophage enhancement of galactosamine hepatotoxicity using a rat hepatocyte culture system. Res Commun Mol Pathol Pharmacol. 1995 Jun; 88(3):327-38.
Score: 0.088
-
Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology. 1995 Apr; 21(4):1045-50.
Score: 0.087
-
Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicol Appl Pharmacol. 1992 Aug; 115(2):234-40.
Score: 0.073
-
Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide. Toxicol Appl Pharmacol. 1990 Sep 01; 105(2):195-208.
Score: 0.064
-
Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol. 1987 Feb 15; 36(4):427-33.
Score: 0.050
-
Acetaminophen hepatotoxicity: studies on the mechanism of cysteamine protection. Toxicol Appl Pharmacol. 1986 Mar 30; 83(1):115-25.
Score: 0.047
-
The mechanisms of cobalt chloride-induced protection against acetaminophen hepatotoxicity. Drug Metab Dispos. 1986 Jan-Feb; 14(1):25-33.
Score: 0.046
-
Role of UDPGA flux in acetaminophen clearance and hepatotoxicity. Xenobiotica. 1984 Jul; 14(7):553-9.
Score: 0.041
-
Biochemical basis for dose response relationships in reactive metabolite toxicity. Adv Exp Med Biol. 1981; 136 Pt A:99-113.
Score: 0.033
-
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology. 1974; 12(4-5):251-71.
Score: 0.020
-
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974; 11(3):151-69.
Score: 0.020
-
Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicol Appl Pharmacol. 1989 Nov; 101(2):356-69.
Score: 0.015
-
Mechanism of decreased acetaminophen glucuronidation in the fasted rat. Biochem Pharmacol. 1988 Mar 15; 37(6):1067-75.
Score: 0.013
-
Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis. Hepatology. 1987 Sep-Oct; 7(5):825-30.
Score: 0.013
-
Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther. 1986 Sep; 238(3):1045-54.
Score: 0.012
-
Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity. Biochem Pharmacol. 1986 Feb 15; 35(4):687-95.
Score: 0.012
-
Mechanism of fasting-induced suppression of acetaminophen glucuronidation in the rat. Adv Exp Med Biol. 1986; 197:697-706.
Score: 0.011
-
Improved method for determination of cellular thiols, disulfides and protein mixed disulfides using HPLC with electrochemical detection. Adv Exp Med Biol. 1986; 197:407-13.
Score: 0.011
-
Vasopressin stimulates thromboxane synthesis in isolated hamster hepatocytes: relation to hepatocyte calcium content. Prostaglandins. 1983 Sep; 26(3):397-408.
Score: 0.010
-
Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther. 1982 Mar; 220(3):504-13.
Score: 0.009
-
Pharmacokinetic considerations in toxicity testing. Drug Metab Rev. 1982; 13(6):983-1007.
Score: 0.009
-
Formation of chemically reactive metabolites of phenacetin and acetaminophen. Adv Exp Med Biol. 1981; 136 Pt B:931-50.
Score: 0.008
-
Glutathione thresholds in reactive metabolite toxicity. Arch Toxicol Suppl. 1980; 3:95-110.
Score: 0.008
-
Acetaminophen overdosage. J S C Med Assoc. 1977 Nov; 73(11):474-80.
Score: 0.007
-
Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide. Pharmacology. 1976; 14(3):205-17.
Score: 0.006
-
Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest. 1975 Aug; 68(2):181-90.
Score: 0.006
-
Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 1974 Jun 01; 14(11):2099-109.
Score: 0.005
-
Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology. 1974; 12(3):129-43.
Score: 0.005
-
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973 Oct; 187(1):195-202.
Score: 0.005
-
Lack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity. Biochem Pharmacol. 1993 Feb 09; 45(3):780-2.
Score: 0.005
-
Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein). J Lab Clin Med. 1987 Jul; 110(1):83-90.
Score: 0.003
-
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974 Oct; 16(4):676-84.
Score: 0.001
-
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973 Oct; 187(1):185-94.
Score: 0.001
-
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973 Oct; 187(1):211-7.
Score: 0.001
-
Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J Pharmacol Exp Ther. 1973 Oct; 187(1):218-27.
Score: 0.001
-
Drug metabolism as a cause of drug toxicity. Drug Metab Dispos. 1973 Jan-Feb; 1(1):418-23.
Score: 0.001